title: Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus.
abstract: BACKGROUND
  The role of anterior pituitary hormones in systemic lupus erythematosus (SLE) remains controversial.
  
  
  OBJECTIVE
  We determined the expression levels of human growth hormone (GH), prolactin (PRL), and their receptors in subjects presenting with SLE, and modulation of disease severity.
  
  
  METHODS
  Forty-seven subjects and ten healthy controls were assessed for possible association between SLE disease activity and levels of serum PRL, GH and thyrotropin-releasing hormone (TRH). In peripheral blood mononuclear cells (PBMC), specific binding and mRNA expression of receptors for GH (GHR), and PRL (PRLR) were determined by receptor-ligand binding assay (RLBA) and RT-PCR. PBMC of recruited subjects were treated with hPRL and rhGH to assess IgG production and antibodies against dsDNA.
  
  
  RESULTS
  In active SLE subjects we found elevated PRL and GH levels. Study subject PBMCs displayed augmented GHR and PRLR protein and mRNA expression. Study subjects also showed a positive correlation in serum PRL levels and specific antibodies against dsDNA, SLE disease activity index (SLEDAI), and proteinuria. However, a negative correlation was found between serum PRL levels and complement component C3. We found a positive correlation between specific binding rates of PRLR and GHR and both SLE activity and dsDNA antibody titers. Enhanced IgG and anti-dsDNA secretion was observed in cultured PBMC stimulated by PRL or GH with/without PHA, PWM, IL-2 or IL-10. In active SLE, a close association was found between augmented PRL and GH levels, expression and specific binding activities of PRLR and GHR, and changes in the specific titer of anti-dsDNA.
  
  
  CONCLUSIONS
  Anterior pituitary hormones play an important role in the pathogenesis of SLE. High levels of growth hormone (GH) and prolactin (PRL) play a role in pathogenesis of SLE, which is correlated with SLE disease activity and antibodies against dsDNA. The mechanism of GH and PRL in SLE was complicated and should be studied further.
authors.affiliation: Department of Dermatology, Huashan Hospital, Fudan University Shanghai 200040, China.
authors.forename: Xiaohua
authors.initials: X
authors.lastname: Zhu
authors.affiliation: Department of Dermatology, Huashan Hospital, Fudan University Shanghai 200040, China.
authors.forename: Jinhua
authors.initials: J
authors.lastname: Xu
authors.affiliation: Department of Dermatology, Huashan Hospital, Fudan University Shanghai 200040, China.
authors.forename: Shujuan
authors.initials: S
authors.lastname: Li
authors.affiliation: Department of Dermatology, Huashan Hospital, Fudan University Shanghai 200040, China.
authors.forename: Wen
authors.initials: W
authors.lastname: Huang
authors.affiliation: Department of Dermatology, Huashan Hospital, Fudan University Shanghai 200040, China.
authors.forename: Feng
authors.initials: F
authors.lastname: Li
keywords: Growth hormone; SLE; prolactin; systemic lupus erythematosus